Ahmet Emin Atik received his BSc and MSc in Chemistry from İzmir Institute of Technology (IZTECH) and earned his PhD from the same university in 2013. Since 2021, he has been working as an Assistant Professor in the Department of Natural Sciences at Acibadem Mehmet Ali Aydinlar University. His research primarily focuses on the gas-phase fragmentation chemistry of peptide ions via mass spectrometry and the characterization of biosimilar monoclonal antibodies using state-of-the-art analytical techniques. Additionally, he has been serving as the Quality Control Manager at Turgut Ilacları A.S. since 2020.
Özge Can received his BS degree in Chemical Engineering from Ege University, Izmir, Turkey in 2001. He completed his master’s studies at the Izmir Institute of Technology and worked as a research and teaching assistant in the Department of Chemical Engineering. He went to the United States in 2004 to obtain his Ph.D. and attended Fenn College of Engineering at Cleveland State University, Cleveland, Ohio. He worked as a research and teaching assistant during his doctoral studies within the Department of Chemical and Biomedical Engineering. He then worked at the University of Delaware, Newark, Delaware, USA as an NIH postdoctoral fellow until 2010. The same year, he was appointed as an Assistant Professor of Medical Biochemistry at the Acibadem University, Istanbul, Turkey. He is a member of TauBetaPi (American National Engineering Honor Society) and a founding member of the Turkish Proteomics Association. He acted as the Vice Dean of the Faculty of Engineering and the Vice President of The Health Policies Research and Application Center at Acibadem University between 2015 and 2021. He became an Associate Professor of Medical Biochemistry in 2016 and a full professor of Medical Engineering in 2021. He is currently the Head of the Department of Biomedical Engineering at Acibadem University. His research topics mainly include Biopharmaceutical Development, Protein Engineering, Peptide Therapeutics, Neurooncology, Point of Care Technologies, and In Vitro Diagnostics.
